Zidovudine Good Manufacturer supply High Quality 30516-87-1
- Molecular Formula:C10H13N5O4
- Molecular Weight:267.244
- Appearance/Colour:Off -white crystalline powder
- Melting Point:106-112 °C
- Refractive Index:47 ° (C=1, H2O)
- Boiling Point:410.43°C (rough estimate)
- PKA:pKa 9.53(H2O t = 25.0±0.1 I = 0.00) (Uncertain)
- Flash Point:9℃
- PSA：134.07000
- Density:1.3382 (rough estimate)
- LogP:-0.74354
Zidovudine (30516-87-1) Usage
Zidovudine, also known as azidothymidine (AZT), is an antiviral agent acting via reverse transcnptase inhibition. It was first launched in the U.K. and subsequently introduced in over a dozen countries for the management of severe manifestations of HIV infection. In patients with AIDS and ARC, zidovudine reduces the risk of opportunistic infections and prolongs survival time. In symptom-free patients it shows promise in halting further immunological deterioration.
How to get the best price on Zidovudine?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Zidovudine . You can buy high quality, low price Zidovudine 30516-87-1 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
